The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants.

Cancer types prostate


Armpilia CI, Dale RG, Coles IP, Jones B, Antipas V.

International Journal of Radiation Oncology Biology Physics
February 1, 2003
Dr. Armpilia reports on and derives equations for the formal mathematics of Biologic Effective Dose. According to the mathematical models that take into account variables related to the ability of certain cancers to grow aggressively even while being irradiated, Dr. Armpilia concludes that Cs-131 will successfully treat a wider range of possible cancer types than other brachytherapy isotopes.

Related posts

Scroll to top